Home Interviews Chordate’s CEO on entering new markets

Chordate’s CEO on entering new markets

Chordate BIM 2023

Chordate’s CEO on entering new markets

22 March, 2023

How does Chordate Medical’s treatment for rhinitis and chronic migraine work? What market interest has the company seen and what strategy is it working with to gain market share? In connection with the BioStock Investor Meeting, the company’s CEO Anders Weilandt talked about this, among other things.

Watch the interview (in Swedish) with Chordate Medical’s CEO Anders Weilandt below:

Also watch Anders Weilandts company presentation of Chordate Medical at the BioStock Investor Meeting below:

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.

Prenumerera på BioStocks nyhetsbrev